Accueil / Scientifiques / Oncogenic inflammation & tumor development axis

Scientific axes : Oncogenic inflammation & tumor development axis

Presentation

Deciphering the sequence of pro-oncogenic events in the
context of inflammation & characterizing tumor heterogeneity
via the tumor microenvironment

Teams

Heterogenity of pancreatic tumorigenesis (PATH)

Leader : Haumaitre Cécile Cros Jérome

Accès

Translational Genomics of pancreatic Neoplasia Heterogeneity (GeNeHetX)

Leader : Nicolle Rémy

Accès

From micro to macro in cancer development

Leader : Sinkus Ralph

Accès

Les dernières publications marquantes

Publication date : 11 November 2025 More

EASL Clinical Practice Guidelines on vascular diseases of the liver

J Hepatol.

Authors : Rautou Pierre-Emmanuel Moga Lucile Virginia Hernandez-Gea Walter Ageno Sarwa Darwish Murad Juan-Carlos Garcia-Pagan Maria Guido Valérie McLin Dhiraj Tripathi Vilgrain Valérie European Association for the Study of the Liver
Publication date : 09 November 2025 More

Liver biopsy quality criteria to exclude cirrhosis in case of suspicion of porto-sinusoidal vascular disorder

JHEP Reports

Authors : Chloé de Broucker Paradis Valérie Maria Luisa Botero Albuquerque Miguel Payancé Audrey Plessier Aurélie Elkrief Laure Durand François Sophie Hillaire Paul-Emile Zafar Juan Carlos Garcia Pagan Rautou Pierre-Emmanuel
Publication date : 06 October 2025 More

Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice

PLoS One.

Authors : Cambier Alexandra Da silva Jennifer Bex-Coudrat Julie Canesi Fanny Lison Lachize Neanne Aurélie Sannier Hélène Mathieu Boedec Erwan Amandine Badie Monteiro Renato